FDA REVIEWING ARTHRITIS DRUGS FOR CANCER LINK

( AP) — Federal regulators have been questioning either a organisation of best-selling arthritis drug done by Abbott Laboratories, Schering-Plough Corp. as well as alternative companies worsen a risk of cancer in youngsters.

Tags: , , , , , , , ,

Related posts

Leave a Comment

Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.